-
Product Insights
![]()
Ridgeback Grp – Pall Mall Press Development – Liverpool
Equip yourself with the essential tools needed to make informed and profitable decisions with our Ridgeback Grp - Pall Mall Press Development - Liverpool report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
![]()
Angelo Gordon/ Ridgeback Grp – Kangaroo Works Residential Complex – Sheffield
Equip yourself with the essential tools needed to make informed and profitable decisions with our Angelo Gordon/ Ridgeback Grp - Kangaroo Works Residential Complex - Sheffield report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
![]()
Angelo Gordon/ Ridgeback Grp – Dumballs Road Residential Complex – Cardiff
Equip yourself with the essential tools needed to make informed and profitable decisions with our Angelo Gordon/ Ridgeback Grp - Dumballs Road Residential Complex - Cardiff report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
![]()
Ridgeback Grp – Outwood Wharf Residential Community – City and Borough of Salford
Equip yourself with the essential tools needed to make informed and profitable decisions with our Ridgeback Grp - Outwood Wharf Residential Community - City and Borough of Salford report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
![]()
Angelo Gordon/ Ridgeback Grp – Kingfisher Quarter Mixed-Use Complex – Cardiff
Equip yourself with the essential tools needed to make informed and profitable decisions with our Angelo Gordon/ Ridgeback Grp - Kingfisher Quarter Mixed-Use Complex - Cardiff report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
![]()
Severe Acute Respiratory Syndrome (SARS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Severe acute respiratory syndrome (SARS) is a serious, potentially life-threatening viral infection caused by virus from the Coronaviridae family. Symptoms include cough, chills and shaking, headache, muscle aches, diarrhea, dizziness, nausea and vomiting. Risk factors include gene variation in the immune system and close contact with someone who has SARS. The SARS - drugs in development research report provides a comprehensive overview on the therapeutics under development for SARS, complete with analysis by stage of development, drug target, mechanism of...
-
Sector Analysis
![]()
COVID-19: Contract Pharmaceutical Development and Manufacturing Relationships
This report examines contract manufacturing agreements for vaccines and therapies targeting COVID-19. It reports that there are more than 1,000 vaccines and therapies in development for COVID-19, and 36 vaccines and therapies approved (or granted emergency use authorization) for COVID-19 (as of report publication). At the beginning of the pandemic, slightly more than half of these agreements were for vaccines; this proportion has risen and continues to rise, as several vaccines have proven their safety and efficacy, received approval, and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.